A controlled trial of a 4-weekly supplement of rifampicin, pyrazinamide and streptomycin in the continuation phase of a 7-month daily chemotherapy regimen for pulmonary tuberculosis

South African Medical Journal

Volumn 86, Issue 8, 1996, Pages 960-965

  Derbyshire, Janet H ^a  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; ARTHRALGIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FOLLOW UP; GYNECOMASTIA; HEADACHE; HOSPITAL PATIENT; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; OUTPATIENT; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL; RASH; RECURRENCE RISK; SPUTUM SMEAR; STOMATITIS; TANZANIA; VESTIBULAR DISORDER;

ADOLESCENT; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; ANTITUBERCULAR AGENTS; BODY WEIGHT; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE, MICROBIAL; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; ISONIAZID; ISONICOTINIC ACIDS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PYRAZINAMIDE; RECURRENCE; RIFAMPIN; SPUTUM; STREPTOMYCIN; TUBERCULOSIS, PULMONARY;

EID: 0029847661     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Fox W. Short-course chemotherapy for pulmonary tuberculosis and some problems of its programme application with particular reference to India. Bull Int Union Tuberc 1985; 60: 40-49.
2. Fox W. Self-administration of medicaments. A review of published work and a study of the problems. In: Proceedings of the XVIth International Tuberculosis Conference held 10 to 14 September 1961, Toronto. Amsterdam: Excerpta Medica, International Congress Series, 1962: No. 44; 1: 307-331.
3. Fox W. Ambulatory chemotherapy in a developing country: clinical and epidemiological studies. In: Birkhauser H. Bloch H, Canetti G, eds. Advances in Tuberculosis Research. Vol. 12. Basel: Karger, 1963: 28-149.
4. Fox W. Short-course chemotherapy for tuberculosis. In: Flenley DC, ed. Recent Advances in Respiratory Medicine. Edinburgh: Churchill Livingstone, 1980: 183-203.
5. Ellard GA, Greenfield CJ. A sensitive urine-test method for monitoring the Ingestion of isoniazid. J Clin Pathol 1977; 30: 84-87.
6. East African/British Medical Research Council Thiacetazone/Diphenylthiourea Investigation. Comparative trials of isoniazid in combination with thiacetazone or a substituted diphenylthiourea (SU 1906) or PAS in the treatment of acute pulmonary tuberculosis in East Africans. Tubercle 1960; 41: 399-423.
7. Allen B, Baker FJ. Mycobacteria: isolation, identification and sensitivity testing. London: Butterworths, 1968.
8. Tsukamura M, Tsukamura S. Differentiation of Mycobacterium tuberculosis and Mycobacterium bovis byp-nitrobenzoic acid susceptibility. Tubercle 1964; 45: 64-65.
9. Gutierrez-Vasquez JM. Further studies on the spot test for the differentiation of tubercle bacilli of human origin from other mycobacteria. Am Rev Respir Dis 1960; 81: 412-414.
10. British Medical Research Council. Co-operative controlled trial of a standard regimen of streptomycin. PAS, and isoniazid and three alternative regimens of chemotherapy in Britain. Tubercle 1973; 54: 99-129.
11. Simon Q. Radiology in epidemiological studies and some therapeutic trials. BMJ 1966; 2: 491-494.
12. International Union Against Tuberculosis and Lung Disease. Antituberculosis regimens of chemotherapy. Recommendations from the Committee on treatment of the IUATLD. Bull Int Union Tuberc Lung Dis 1988; 63: 60-64.
13. American Thoracic Society. Treatment of tuberculosis and tuberculosis infection in adults and children. Am Rev Respir Dis 1986; 134: 355-363.
14. Ministère de la Santé (République Algérienne Démocratique et Populaire). Guide technique à l'usage des médecins responsables de la lutte antituberculeuse dans les secteurs sanitaires. Alger: Ministère de la Santé, 1980 (MA/DGS/DP No. 832).
15. Third East African/British Medical Research Council Study. Controlled clinical trial of four short-course regimens of chemotherapy for two durations in the treatment of pulmonary tuberculosis. Second report. Tubercle 1980; 61: 59-69.
16. Second East African/British Medical Research Council Study. Controlled clinical trial of four 6-month regimens of chemotherapy for pulmonary tuberculosis. Second report. Am Rev Respir Dis 1976; 114: 471-475.
17. East and Central African/British Medical Research Council Fifth Collaborative Study. Controlled clinical trial of 4 short-course regimens of chemotherapy (three 6-month and one 8-month) for pulmonary tuberculosis. First report. Tubercle 1983; 64: 153-166.
18. Ellard GA. Chemotherapy of leprosy. Br Med Bull 1988; 44: 775-790.
19. Tanzania/British Medical Research Council Study. Controlled clinical trial of two 6-month regimens of chemotherapy in the treatment of pulmonary tuberculosis. Am Rev Respir Dis 1985; 133: 727-731.
20. Singapore Tuberculosis Service/British Medical Research Council. Assessment of a daily combined preparation of isoniazid, rifampicin, and pyrazinamide in a controlled trial of three 6-month regimens for smear-positive pulmonary tuberculosis. Am Rev Respir Dis 1991; 143: 707-712.
21. Dutt AK, Jones L. Stead WW. Short-course chemotherapy for tuberculosis with largely twice-weekly isoniazid-rifampicin. Chest 1979; 75: 441-447.
22. Montaner LG, Leston JM, Cetrangolo A, et al. Simplified short course treatment of pulmonary tuberculosis: experience with a regimen of ethambutol, rifampicin and isoniazid for 2 months followed by isoniazid or rifampicin for 4 months. Bull Int Union Tuberc 1976; 51: 87-89.
23. Hong Kong Chest Service/Tuberculosis Research Centre, Madras/British Medical Research Council. A double-blind placebo-controlled clinical trial of 3 antituberculosis chemoprophylaxis regimens in patients with silicosis in Hong Kong. Am Rev Respir Dis 1992; 145: 36-41.
24. Singapore Tuberculosis Service/British Medical Research Council. Controlled trial of intermittent regimens of rifampicin plus isoniazid for pulmonary tuberculosis in Singapore. The results up to 30 months. Am Rev Respir Dis 1977; 116: 807-820.
25. Mitchison DA, Ellard GA, Grosset J. New antibacterial drugs for the treatment of mycobacterial disease in man. Br Med Bull 1988; 44: 757-774.
26. Dhillon J, Dickinson J, Guy JA, et al. Activity of two long-acting rifamycins, rifapentine and FCE 22807, in experimental murine tuberculosis. Tubercle Lung Dis 1992; 73: 116-123.